Hemab announced a $135 million Series B financing led by Access Biotechnology

Biotech Health services

Investments

17 February 2023

Hemab (company)

Biotech Health services

Total investments received (USD): 347m

Round value (USD): 135m

Round investors: HealthCap Invus Maj Invest Novo A/S RA Capital Management Deep Track Capital Access Biotechnology Avoro Ventures Rock Springs Capital

Company: Hemab

Industry: Biotech Health services

Related deals

ITM in a €255M investment round led by Temasek

Biotech Health services Pharma

Investments 06 June 2023

Alentis Therapeutics raised $105m in Series C funding led by Jeito Capital

Biotech Health services Manufacturing

Investments 09 April 2023

Noema Pharma raised CHF 103 million in Series B funding led by Forbion and joined by Jeito Capital, UPMC, Sofinnova Partners, Gilde Healthcare and Invus

Biotech Health services

Investments 03 March 2023

Polytech in a NOK 1.45 billion equity deal backed by FSN Capital and Verdane

Energy Manufacturing

Investments 09 January 2023

Danske Commodities increases equity by 3.5 billion euro

Energy Marketplace

Investments 17 December 2022

Menu

Hemab announced a $135 million Series B financing led by Access Biotechnology

Share:

Hemab (company)

Related deals

ITM in a €255M investment round led by Temasek

Alentis Therapeutics raised $105m in Series C funding led by Jeito Capital

Noema Pharma raised CHF 103 million in Series B funding led by Forbion and joined by Jeito Capital, UPMC, Sofinnova Partners, Gilde Healthcare and Invus

Polytech in a NOK 1.45 billion equity deal backed by FSN Capital and Verdane

Danske Commodities increases equity by 3.5 billion euro

Sidebar

Verticals

Benelux

DACH

Nordics and Baltics

Western Europe